Human African Trypanosomiasis Presenting at Least 29 Years after Infection—What Can This Teach Us about the Pathogenesis and Control of This Neglected Tropical Disease?

PLoS Neglected Tropical Diseases

Volumn 8, Issue 12, 2014, Pages

  Sudarshi, Darshan ^a   Lawrence, Sarah ^a   Pickrell, William Owen ^b   Eligar, Vinay ^c   Walters, Richard ^b,c   Quaderi, Shumonta ^a   Walker, Alice ^a   Capewell, Paul ^d   Clucas, Caroline ^d   Vincent, Angela ^e   Checchi, Francesco ^f   MacLeod, Annette ^d   Brown, Michael ^a,f  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

^c PRINCESS OF WALES HOSPITAL   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AZATHIOPRINE; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; CARDIOLIPIN ANTIBODY; CEFTRIAXONE; DOXYCYCLINE; EFLORNITHINE; HU ANTIBODY; HYDROCORTISONE; NIFURTIMOX; PREDNISOLONE; TIABENDAZOLE; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; BRADYKINESIA; CASE REPORT; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EOSINOPHILIA; EPIDEMIC ENCEPHALITIS; EPIGLOTTITIS; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; LYME DISEASE; MALE; MENINGOENCEPHALITIS; MENTAL INSTABILITY; MIDDLE AGED; NORMOCHROMIC NORMOCYTIC ANEMIA; OSTEOPOROSIS; PARKINSONISM; PERSONALITY DISORDER; PLASMAPHERESIS; PROLACTIN BLOOD LEVEL; SHUFFLING GAIT; SOMNOLENCE; STRONGYLOIDES; TESTOSTERONE BLOOD LEVEL; TONIC CLONIC SEIZURE; TRACHEOSTOMY; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 84928227088     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003349     Document Type: Article

References (30)

1. World Health Organisation (2013) Control and surveillance of human African trypanosomiasis. World Health Organ Tech Rep Ser: 1–237.
2. Bucheton B, MacLeod A, Jamonneau V, (2011) Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol 33: 438–447.
3. Checchi F, Filipe JA, Barrett MP, Chandramohan D, (2008) The natural progression of Gambiense sleeping sickness: what is the evidence? PLoS Negl Trop Dis 2: e303.
4. Todd JL, (1924) After-history of African trypanosomiasis, 1911–1924. BMJ169: 298.
5. Cates JE, Mcilroy M, (1951) African trypanosomiasis in a British soldier. Br Med J 2: 401.
6. Harding RD, Hutchinson MP, (1948) Sleeping sickness of an unusual type in Sierra Leone and its attempted control. Trans R Soc Trop Med Hyg 41: 481–512.
7. Jamonneau V, Ilboudo H, Kabore J, Kaba D, Koffi M, et al. (2012) Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis 6: e1691.
8. Lapierre J, Coste M, (1963) Contribution a l'etude d'une souche de Trypanosoma gambiense (Feo) isolee d'un cas humain caracterise par une duree de plus de 20 ans de parasitemie cliniquement inappreciable. Annales de Parasitologie 38: 757–782.
9. Pinard M, Brumpt L, Raymoneau M, (1939) Présentation d'un malade atteint de trypanosomiase révélée tardivement par des convulsions et du prurit. Bull et Mém de la Soc Méd Hôp de Paris 55: 324–328.
10. Dyleff P, (1932) Quelques reflexions sur la disparition spontanee des trypanosomes chez trois europeens reconnus porteurs des trypanosomes. Bull Soc Pathol Exot 25: 956–958.
11. Barlovatz A, (1933) Course, prognosis and classification of human trypanosomiasis. Ann Trop Med Parasitol 28: 1–20.
12. Baonville H, Ley J, Titeca J, (1934) Psychose hallucinatoire chez un trypanosomé. Journal belge de neurologie et psychiatrie 34: 129–138.
13. Gibson W, Nemetschke L, Ndung'u J, (2010) Conserved sequence of the TgsGP gene in Group 1 Trypanosoma brucei gambiense. Infect Genet Evol 10: 453–458.
14. Garcia A, Courtin D, Solano P, Koffi M, Jamonneau V, (2006) Human African trypanosomiasis: connecting parasite and host genetics. Trends Parasitol 22: 405–409.
15. Courtin D, Milet J, Sabbagh A, Massaro JD, Castelli EC, et al. (2013) HLA-G 3' UTR-2 haplotype is associated with Human African trypanosomiasis susceptibility. Infect Genet Evol 17: 1–7.
16. Chappuis F, Loutan L, Simarro P, Lejon V, Buscher P, (2005) Options for field diagnosis of human african trypanosomiasis. Clin Microbiol Rev 18: 133–146.
17. Koffi M, Solano P, Denizot M, Courtin D, Garcia A, et al. (2006) Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a potential human reservoir of parasites? Acta Trop 98: 183–188.
18. Ilboudo H, Jamonneau V, Camara M, Camara O, Dama E, et al. (2011) Diversity of response to Trypanosoma brucei gambiense infections in the Forecariah mangrove focus (Guinea): perspectives for a better control of sleeping sickness. Microbes Infect 13: 943–952.
19. Koffi M, De Meeus T, Bucheton B, Solano P, Camara M, et al. (2009) Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa. Proc Natl Acad Sci U S A 106: 209–214.
20. Van den Bossche P, Ky-Zerbo A, Brandt J, Marcotty T, Geerts S, et al. (2005) Transmissibility of Trypanosoma brucei during its development in cattle. Trop Med Int Health 10: 833–839.
21. Camara O, Camara M, Lejon V, Ilboudo H, Sakande H, et al. (2014) Immune trypanolysis test with blood spotted on filter paper for epidemiological surveillance of sleeping sickness. Trop Med Int Health 19: 828–831.
22. Simarro PP, Franco JR, Diarra A, Ruiz Postigo JA, Jannin J. (2013) Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination. Res Rep Trop Med 4: 1–6.
23. Walker M, Kublin JG, Zunt JR, (2006) Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis 42: 115–125.
24. Meda HA, Doua F, Laveissiere C, Miezan TW, Gaens E, et al. (1995) Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Cote d'Ivoire. Trans R Soc Trop Med Hyg 89: 639–643.
25. Diazgranados CA, Saavedra-Trujillo CH, Mantilla M, Valderrama SL, Alquichire C, et al. (2009) Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis 9: 324–330.
26. Sternberg JM, (2004) Human African trypanosomiasis: clinical presentation and immune response. Parasite Immunol 26: 469–476.
27. Price HP, Hodgkinson MR, Curwen RS, MacLean LM, Brannigan JA, et al. (2012) The orthologue of Sjogren's syndrome nuclear autoantigen 1 (SSNA1) in Trypanosoma brucei is an immunogenic self-assembling molecule. PLoS ONE 7: e31842.
28. Migchelsen SJ, Buscher P, Hoepelman AI, Schallig HD, Adams ER, (2011) Human African trypanosomiasis: a review of non-endemic cases in the past 20 years. Int J Infect Dis 15: e517–524.
29. Schmid C, Kuemmerle A, Blum J, Ghabri S, Kande V, et al. (2012) In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness. PLoS Negl Trop Dis 6: e1920.
30. Vincent A, Bien CG, Irani SR, Waters P, (2011) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 10: 759–772.